Home

​for me it is difficult to understand how best to utilize focus group collaborations and where they fit into the new community model. Any explanation is appreciated. ------------------------------ Varsha Bhatt-Mehta, Pharm.D., MS, FCCP Clinical Professor ...

Happy to assist and reply the questions in which I have knowledge and experience as soon as possible to help the other Pharmaceutical Scientists. ------------------------------ Gaurang Bhavsar Manager, R&D and RA Sunrise Pharmaceutical, Inc. Rahway NJ ...

Awesome suggestions, Ed. ------------------------------ Kim HuynhBa PHARMALYTIK Consulting Executive Director khuynhba@pharmalytik.com Newark DE USA ------------------------------

With the release of new and updated guidance and the increasing complexity of the equipment involved in new emerging technologies,  new approaches to old problems may be found.   I am very interested in discussions about how to leverage method validation ...

​Thanks to the ETDG, the AAPS software validation group got its start. The objective of the software validation group was to work out strategies and techniques for the validation of emergent technologies (ET).   As ET may be constructed by new vendors ...

Hello, I've not posted a new message before so if this is not the path for posting please let me know. If this is correct my message is below. Thank you, Stephanie In 2012 the Emerging Technologies Discussion ...